Indefinite Delivery Contract SPE2DX16D1914

The federal contract IDV award SPE2DX16D1914 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at up to $999,999,999 and runs through December 2025. Under this IDC, Amerisourcebergen is delivering a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The task orders issued under this contract cover a diverse array of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health, and infectious disease prevention. The contract does not have any set-aside designations, indicating open competition. The place of performance for the delivery orders is Conshohocken, PA. This IDC serves as a primary vehicle for the DLA to efficiently procure critical pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

In addition to the DLA Troop Support Medical IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for the delivery of similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and essential pharmaceutical and medical supply needs of multiple government agencies on a large scale through streamlined contracting mechanisms.